Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 (CovidTox)

Groupe Hospitalier Pitie-Salpetriere

Status: Completed

Conditions: Acute Kidney Injury; ARDS, Human; Iatrogenic Disease; Coronavirus

Treatments: Drug: Any drug used to treat Covid-19

Study type: Observational

Funder types: Other

Identifiers

NCT04314817

CIC1421-20-04

Details and patient eligibility

About

The outbreak of Covid-19 started several clinical trials and treatment experiments all over the world in the first months of 2020. This study investigates reports of adverse events related to used molecules, including but not limited to protease inhibitors (lopinavir/ritonavir), chloroquine, azithromycin, remdesivir and interferon beta-1a. Analyses of reports also include the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).

Enrollment: 1,000 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• all patients treated for Covid-19

Exclusion criteria

• Chronology not compatible between the drug and the toxicity

Trial design

1,000 participants in 1 patient group

Patients treated for Covid-19

Treatment:

Drug: Any drug used to treat Covid-19